Researchers develop magnetic nanoparticles for bone cancer treatment

Scientists from Brazil and Portugal have created a magnetic nanocomposite that targets bone cancer cells while promoting bone regeneration. The material uses heat from a magnetic field to destroy tumors and a bioactive coating to aid healing. This innovation could enable less invasive therapies for bone tumors.

Researchers from Brazil and Portugal have engineered a magnetic core-shell nanocomposite to combat bone cancer and support tissue repair. Published in Magnetic Medicine in 2025, the material consists of iron oxide nanoparticles coated with bioactive glass. This structure allows it to generate heat under an alternating magnetic field, enabling magnetic hyperthermia to ablate tumor cells selectively without widespread damage to healthy tissue.

The bioactive glass layer enhances the material's integration with bone. In tests using simulated body fluid, the nanocomposites rapidly formed apatite, a mineral akin to that in natural bone, indicating strong potential for bonding and regeneration. Among various formulations, the one with elevated calcium content excelled, showing the quickest mineralization and most robust magnetic properties.

"Magnetic bioactive nanocomposites are very promising for bone cancer therapy because they can simultaneously ablate tumors through magnetic hyperthermia and support new bone growth," stated Dr. Ângela Andrade, the lead author. She highlighted the challenge overcome: achieving both high magnetization and bioactivity in a single material.

Further, Andrade noted, "Among the tested formulations, the one with a higher calcium content demonstrated the fastest mineralization rate and the strongest magnetic response, making it an ideal candidate for biomedical applications."

This dual-function approach addresses both tumor elimination and structural recovery in one procedure. "This study provides new insights into how surface chemistry and structure influence the performance of magnetic biomaterials," Andrade added, suggesting pathways for safer, more effective clinical tools in oncology and regenerative medicine.

The work, detailed by authors including Andreia Batista and José Domingos Fabris, appears in Magnetic Medicine (2025; 1(3):100039). It represents a step toward multifunctional nanomaterials for minimally invasive bone cancer treatments.

관련 기사

Illustration of scientists in a lab studying a miniature human bone marrow model, depicting blood cell production for medical research.
AI에 의해 생성된 이미지

Researchers build functional miniature human bone marrow model

AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨

Scientists at the University of Basel report a three-dimensional human bone marrow model built entirely from human cells. The lab-grown system replicates the endosteal niche and sustains blood cell production for weeks, a step that could accelerate blood cancer research and reduce some animal testing.

Scientists at Oregon State University say they have engineered an iron-based nanomaterial that exploits acidic, peroxide-rich conditions inside tumors to generate two types of reactive oxygen species and kill cancer cells while largely sparing healthy cells. In mouse tests using human breast-cancer tumors, the team reports complete tumor regression without observable adverse effects, though the work remains preclinical.

AI에 의해 보고됨

Scientists at RMIT University have created tiny molybdenum oxide nanodots that destroy cancer cells by amplifying their internal stress, while leaving healthy cells largely intact. In lab tests, these particles proved three times more effective against cervical cancer cells than healthy ones. The early-stage research points to a potential for more precise cancer treatments.

Scientists have developed an ultra-sensitive Raman imaging system that identifies cancerous tissue by detecting faint light signals from nanoparticles bound to tumor markers. This technology, far more sensitive than current tools, could accelerate cancer screening and enable earlier detection. Led by researchers at Michigan State University, the system promises to bring advanced imaging into clinical practice.

AI에 의해 보고됨 사실 확인됨

A Northwestern University team reports that redesigning the chemotherapy drug 5‑fluorouracil as a spherical nucleic acid markedly increased its cancer‑cell uptake and efficacy in acute myeloid leukemia models, with no observable side effects, according to a study published October 29 in ACS Nano.

A small study from researchers in India has found that a short course of an oral combination of resveratrol and copper was associated with reduced biological markers of aggressiveness in glioblastoma tumors, without reported side effects. Patients who took the nutraceutical before surgery showed lower levels of several key cancer-related markers in their tumor samples, and the approach targets harmful DNA-containing particles released from dying cancer cells.

AI에 의해 보고됨

Researchers at the University of Southampton have created a new class of antibodies designed to strengthen the immune system's attack on cancer cells. These antibodies cluster receptors on T cells to amplify activation signals that tumors typically weaken. Early laboratory tests indicate they outperform standard antibodies in mobilizing cancer-killing immune cells.

 

 

 

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부